| Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation Á Chamorro, U Dirnagl, X Urra, AM Planas The Lancet Neurology 15 (8), 869-881, 2016 | 1101 | 2016 |
| The immunology of acute stroke A Chamorro, A Meisel, AM Planas, X Urra, D Van De Beek, R Veltkamp Nature reviews neurology 8 (7), 401-410, 2012 | 729 | 2012 |
| Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra I Ferrer, AM Planas Journal of Neuropathology & Experimental Neurology 62 (4), 329-339, 2003 | 618 | 2003 |
| Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression A Chamorro, X Urra, AM Planas Stroke 38 (3), 1097-1103, 2007 | 600 | 2007 |
| Action plan for stroke in Europe 2018–2030 B Norrving, J Barrick, A Davalos, M Dichgans, C Cordonnier, A Guekht, ... European stroke journal 3 (4), 309-336, 2018 | 530 | 2018 |
| Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88‐dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways R Gorina, M Font‐Nieves, L Márquez‐Kisinousky, T Santalucia, ... Glia 59 (2), 242-255, 2011 | 525 | 2011 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 508 | 2021 |
| Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke N Vila, J Castillo, A Dávalos, A Esteve, AM Planas, Á Chamorro Stroke 34 (3), 671-675, 2003 | 456 | 2003 |
| Inhibition of tumor angiogenesis by cannabinoids C Blázquez, ML Casanova, A Planas, T Gómez del Pulgar, C Villanueva, ... The FASEB journal 17 (3), 1-16, 2003 | 390 | 2003 |
| Neutrophil recruitment to the brain in mouse and human ischemic stroke I Perez-de-Puig, F Miró-Mur, M Ferrer-Ferrer, E Gelpi, J Pedragosa, ... Acta neuropathologica 129, 239-257, 2015 | 387 | 2015 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 370 | 2021 |
| Expression and activation of matrix metalloproteinase-2 and-9 in rat brain after transient focal cerebral ischemia AM Planas, S Solé, C Justicia Neurobiology of disease 8 (5), 834-846, 2001 | 341 | 2001 |
| A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart JJ Fuentes, MA Pritchard, AM Planas, A Bosch, I Ferrer, X Estivill Human molecular genetics 4 (10), 1935-1944, 1995 | 323 | 1995 |
| Improving outcome after stroke: overcoming the translational roadblock M Endres, B Engelhardt, J Koistinaho, O Lindvall, S Meairs, JP Mohr, ... Cerebrovascular diseases 25 (3), 268-278, 2008 | 307 | 2008 |
| Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial Á Chamorro, S Amaro, M Castellanos, T Segura, J Arenillas, ... The Lancet Neurology 13 (5), 453-460, 2014 | 302 | 2014 |
| Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats C Justicia, J Panés, S Solé, A Cervera, R Deulofeu, A Chamorro, ... Journal of Cerebral Blood Flow & Metabolism 23 (12), 1430-1440, 2003 | 298 | 2003 |
| The early systemic prophylaxis of infection after stroke study: a randomized clinical trial A Chamorro, JP Horcajada, V Obach, M Vargas, M Revilla, F Torres, ... Stroke 36 (7), 1495-1500, 2005 | 286 | 2005 |
| Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? M Vargas, JP Horcajada, V Obach, M Revilla, A Cervera, F Torres, ... Stroke 37 (2), 461-465, 2006 | 280 | 2006 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 277 | 2022 |
| Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia G Llovera, K Hofmann, S Roth, A Salas-Pérdomo, M Ferrer-Ferrer, ... Science translational medicine 7 (299), 299ra121-299ra121, 2015 | 273 | 2015 |
Xabier UrraHead of Neurology, Hospital Clínic BarcelonaGeverifieerd e-mailadres voor clinic.cat
